Glenn R. Mattes's Net Worth
$3.41 Million
Who is Glenn R. Mattes?
Glenn R. Mattes has an estimated net worth of $3.41 Million. This is based on reported shares across multiple companies, which include TFF Pharmaceuticals, Inc., and Arno Therapeutics, Inc.
SEC CIK
Glenn R. Mattes's CIK is 0001568678
Past Insider Trading and Trends
2013 was Glenn R. Mattes's most active year for acquiring shares with 10 total transactions. Glenn R. Mattes's most active month to acquire stocks was the month of September. 2021 was Glenn R. Mattes's most active year for disposing of shares, totalling 6 transactions. Glenn R. Mattes's most active month to dispose stocks was the month of December. 2020 saw Glenn R. Mattes paying a total of $347,075.00 for 290,830 shares, this is the most they've acquired in one year. In 2020 Glenn R. Mattes cashed out on 277,660 shares for a total of $2,091,805.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TFF Pharmaceuticals, Inc. (TFFP) Snapshot price: $1.9
President and CEOGlenn R. Mattes owns 36,000 units of Common Stock which is worth $68,400.00. In the year 2019 Glenn R. Mattes filed a total of 12 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +80.00% | 16K |
$4.78 | $76,480.00 | 36K |
May 16
| |||
Form 4
| +100.00% | 10K |
$7.10 | $71,000.00 | 20K |
Sep 16
| |||
Form 4
|
—
|
0
|
$9.77 | -$727,000.00 | 10K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
$9.66 | -$572,800.00 | 10K |
Scheduled
|
Feb 16
| ||
Form 4
| -15.00% | -3.00K |
$9.88 | -$651,400.00 | 17K |
Scheduled
|
Sep 25 - Jan 15
| ||
Form 4
|
—
|
0
|
$8.91 | -$384,900.00 | 10K |
Scheduled
|
Dec 23
| ||
Form 4
|
—
|
0
|
$8.75 | -$1,359,830.85 | 10K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29 - Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 4/A
|
∞
| 20K |
$5.00 | $100,000.00 | 20K |
Oct 25 - Oct 29
| |||
Form 4
|
∞
| 10K |
$5.00 | $50,000.00 | 10K |
Oct 25 - Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arno Therapeutics, Inc No price found
President & CEOGlenn R. Mattes owns 77,203 units of Common Stock. In the year 2013 Glenn R. Mattes acquired a total of 54,605 shares in Arno Therapeutics, Inc at a cost of $60,288.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 4
| +137.65% | 44.72K |
$2.40 |
—
| 77.2K |
Oct 29
| |||
Form 4
| +1.26% | 3.22K |
$0.30 | $966.60 | 259.89K |
May 28
| |||
Form 4
| +1.32% | 3.33K |
$0.30 | $999.90 | 256.67K |
Apr 29
| |||
Form 4
| +1.33% | 3.33K |
$0.30 | $999.90 | 253.33K |
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||